Calcivis is an innovative medical devices company focused on revolutionising the management of dental caries or ‘tooth decay’. Calcivis brings together novel biotechnology approaches and world-class device development expertise and is at the forefront of applying biotechnology to dentistry.
The Calcivis® Caries Activity and Demineralisation Imaging System is a sophisticated device that will for the first time allow dentists to ‘see’ active demineralisation for assessment and management of dental caries and other conditions such as acid erosion.
Real-time assessment of caries activity and demineralisation with the Calcivis System will allow for tailored, rational, evidence-based treatment in line with dental best practice.
In 2016 Calcivis won a place on the London Stock Exchange’s ELITE Programme for the UK’s most exciting and ambitious high growth businesses.